NPHS1 and endothelial dysfunction: The daily CPE treatment prevents endothelial dysfunction and the development of cardiovascular complications, such as SAH, reducing oxidative stress and proteinuria [31] by preserving nephrin in the podocyte diaphragm, as observed with other renal pathologies [17].